DoD supports further development of plasma technology

10/6/2011 | American City Business Journals

The Defense Department has awarded Entegrion a $43.7 million contract to further develop the biotech company's Resusix plasma product. The technology, which the company says provides a better alternative to frozen blood plasma, would enable military staffers to dry and store plasma that they could use in combat situations.

View Full Article in:

American City Business Journals

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
President/Chief Executive Officer
MedCost
Winston-Salem, NC
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
Director, Payer Marketing
Avalere Health
Washington, DC
Actuary
Meridian Health Plan
Detroit, MI
Chief Medical Officer, Texas Children's Health Plan
Cejka Executive Search for Texas Childre's Health Plan
Houston, TX